Literature DB >> 16250024

Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy.

Kazumasa Suzuki, Shuichi Awata, Kae Nakagawa, Takehisa Takano, Hiroo Matsuoka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16250024     DOI： 10.1002/mds.20749

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  5 in total

1.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12

2.  Quantitative evaluation of electroconvulsive therapy for Parkinson's disease with refractory psychiatric symptoms.

Authors:  Kenya Nishioka; Ryota Tanaka; Hideki Shimura; Kazuoki Hirano; Taku Hatano; Koichi Miyakawa; Heii Arai; Nobutaka Hattori; Takao Urabe
Journal:  J Neural Transm (Vienna)       Date:  2014-04-18       Impact factor: 3.575

Review 3.  Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.

Authors:  Julian N Trollor; Xiaohua Chen; Perminder S Sachdev
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 4.  Electroconvulsive Therapy and Movement Disorders. New Perspectives on A Time-Tested Therapy.

Authors:  Pedro J Garcia Ruiz
Journal:  Mov Disord Clin Pract       Date:  2021-03-09

5.  Treatment of Catatonia in Parkinson's Disease with Electroconvulsive Therapy.

Authors:  Vinutha Ramesh; Ashish Sharma; Veenita Sharma; Aditya Somani
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.